SABBY Management, LLC, 10% Owner at ReShape Lifesciences Inc. (RSLS), bought 5,766 shares at $0.28 ($2K) on 2019-01-22, disclosed to the SEC on 2019-01-24.
Open-market purchase of $2k RSLS by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| VLCN | BUY | 2024-08-28 | $5K | — | Filing → |
| VLCN | BUY | 2024-08-26 | $11K | — | Filing → |
| VLCN | SELL | 2024-08-26 | $134K | — | Filing → |